Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.19ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-11794Hong Kong
B.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.19SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
B.19SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-27219.1China
B.19SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-10732.5China
B.19SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.19SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.19EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-7551.2South Korea
B.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-2308.74South Korea
B.19ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-12650.3Germany
B.19ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-11298.7Germany
B.19EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.19EHuang-EGCAGCAGTACGCACACAATC20552637626357R-5161.21China
B.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-11307.3China
B.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-13571.9China
B.19NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-22844.7China
B.19NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-14962.8China
B.19NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18418.6Thailand
B.19NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4177.06Thailand
B.19NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-5354.24US
B.19NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
B.19NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
B.19NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1575.86US
B.19NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.19NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-15518.6US
B.19NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.19NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.19NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-12250.3Germany
B.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-14127.1South Korea
B.19NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.19NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.19NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-15770Japan
B.19NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.19NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-17988.2Hong Kong
B.19NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F362.924China
B.19NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.19NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.19ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-1885.04Japan
B.19ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-25657.5Japan
B.19ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-15678.1Japan
B.19ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-4616.71Japan
B.19ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
B.19ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-9875.64Japan
B.19SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
B.19SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
B.19SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-20966Japan
B.19SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-22193.2Japan
B.19SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-21400.8Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used